Ormat Technologies Inc (ORA)
Official siteUTILITIES • UTILITIES - RENEWABLE • NYSE
Market Cap: $5.56B
Last updated: Nov 17, 2026 at 11:06 AM ET
Ormat Technologies Inc (ORA) Stock Forecast
Analysts expect Ormat Technologies (ORA) to earn $2.91 per share in the fiscal year ending Dec 31, 2026, on revenue of $1.19B. Of 14 analysts, 8 rate the stock Buy or Strong Buy, 6 Hold and 0 Sell or Strong Sell, for a consensus of Buy. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 1 down.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 14 ratings average 2.14, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 57% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 4 | 28.6% |
| Buy | 4 | 28.6% |
| Hold | 6 | 42.9% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 14
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus falls 9.3% and revenue estimates fall 4.2%.
- Fiscal year ending Dec 31, 2026
- $2.91
- EPS consensus, revenue $1.19B
- Fiscal year ending Dec 31, 2027
- $2.64
- EPS consensus, revenue $1.14B
- Next report
- Feb 23, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $2.91 | $2.73 to $3.13 | 9 | $1.19B | $1.17B to $1.20B | 12 |
| Dec 31, 2027 | $2.64 | $2.34 to $3.08 | 10 | $1.14B | $1.01B to $1.37B | 13 |
Quarterly Estimates
The EPS consensus rises from $0.52 for the quarter ending Dec 31, 2026 to $0.70 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $0.52 | $0.22 to $0.82 | 13 | $257.12M | $241.08M to $283.05M | 11 |
| Mar 31, 2027 | $0.70 | $0.58 to $0.76 | 5 | $291.05M | $267.00M to $324.09M | 4 |
Estimate Revisions
Across the 3 periods below, the last 30 days brought 5 upward and 5 downward EPS revisions.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 2 | 1 |
| Fiscal year ending Dec 31, 2027 | 1 | 2 |
| Quarter ending Mar 31, 2027 | 2 | 2 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 12.4% from $2.59.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $2.91 | $2.70 | $2.67 | $2.63 | $2.59 | +12.2% |
| Fiscal year ending Dec 31, 2027 | $2.64 | $2.55 | $2.55 | $2.56 | $2.63 | +0.1% |
| Quarter ending Mar 31, 2027 | $0.70 | $0.66 | $0.69 | $0.72 | $0.72 | -3.3% |
Frequently Asked Questions About ORA
What is the ORA stock forecast?
Consensus analyst estimates put Ormat Technologies's EPS at $2.91 for the fiscal year ending Dec 31, 2026, on revenue of $1.19B. The consensus rating from 14 analysts is Buy.
How do analysts rate ORA stock?
Of 14 analysts covering Ormat Technologies, 4 rate it Strong Buy, 4 Buy, 6 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from ORA next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $2.91, with estimates from $2.73 to $3.13 from 9 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $2.64, with estimates from $2.34 to $3.08 from 10 analysts.
What revenue do analysts expect from Ormat Technologies next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $1.19B, with estimates from $1.17B to $1.20B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $1.14B, with estimates from $1.01B to $1.37B.
How many analysts cover ORA?
14 analysts rate Ormat Technologies stock, and 9 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
ORA pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors